Glucocorticosteroids inhibit leukotriene production

Annals of Allergy, Asthma and Immunology

Volumn 78, Issue 5, 1997, Pages 497-505

  Crocker, I Caroline ^b   Zhou, Chang Yi ^b   Bewtra, Againdra K ^b   Kreutner, William ^a   Townley, Robert G ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BECLOMETASONE DIPROPIONATE; CALCIMYCIN; GLUCOCORTICOID; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 3; MOMETASONE FUROATE; PEPTIDOLEUKOTRIENE;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; BASOPHIL; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MIXED LEUKOCYTE CULTURE; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 1842367341     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63238-3     Document Type: Article

References (41)

1. 4 receptor antagonist. Ann NY Acad Sci 1991;629:148-156.
2. Chanarin N, Johnston SL. Leukotrienes as a target in asthma therapy. Drugs 1994;47(1):12-24.
3. Skoner DP, Lee L, Doyle WJ, et al. Nasal physiology and inflammatory mediators during natural pollen exposure. Ann Allergy 1990;65:206-210.
4. Hedqvist P, Raud J, Palmertz U, et al. Eicosanoids as mediators and modulators of inflammation. Adv Prostaglandin Thromboxane Leukot Res 1991; 216:537-543.
5. Woodward DF, Weichman BM, Gill CA, Wasserman MA. The effect of synthetic leukotrienes on tracheal microvascular permeability. Prostaglandins 1983;25:131-142.
6. 4 increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982;126: 449-451.
7. Valone FH, Boggs JM, Goetzl EJ. Lipid mediators of hypersensitivity and inflammation. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds Allergy: Principles and Practice. Mosby: Baltimore, 1993:302-319.
8. Schleimer RP, MacGlashan DW Jr, Peters SP, et al. Characterisation of the inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis 1986;133:614-617.
9. 4 production from human eosinophils in vitro: role of eosinophil chemotactic factors on eosinophil activation. J Immunol 1988;141: 4291-4297.
10. MacGlashan GW Jr, Schleimer RP, Peters SP, et al. Comparative studies of human basophils and mast cells. Fed Proc 1983;42:2504-2509.
11. Gounni AS, Lamkhloued B, Ochial K, et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994;367: 183-186.
12. Lichtenstein LM, Bochner BS. The role of basophils in asthma. Ann NY Acad Sci 1991;629:48-61.
13. Kurimoto Y, De Week AL, Dahinden CA. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation. Eur J Immunol 1991;21: 361-368.
14. Hiria K, Morita Y, Misaki Y, et al. Modulation of human basophil histamine release by hematopoietic growth factors. J Immunol 1988;141: 3957-3964.
15. Schleimer RP, Derse CP, Friedman B, et al. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 1989;143:1310-1317.
16. Haisa A, Chang HS, Bewtra AK, et al. Long-term cultured mouse mast cells: Ultrastructure, histamine, and leukotriene levels. Int Arch Allergy Immunol 1992;98:169-177.
17. Sugiyama H, Eda R, Hopp RJ, et al. Importance of interleukin-3 on histamine release from human basophils. Ann Allergy 1993;71:391-395.
18. MacGlashan DW Jr, Hubbard WC. IL-3 alters free arachidonic acid generation in C5a-stimulated human basophils. J Immunol 1993;151: 6358-6369.
19. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993; 177:605-611.
20. Bischoff SC, De Weck AL, Dahinden CA. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci USA 1990;87:6813-6817.
21. Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-778.
22. Schleimer RP. Glucocorticoids: their mechanisms of action and use in allergic diseases. In: Allergy Principles and Practice 3rd Ed E. Middleton, CE Reed, EF Ellis, NF Adkinson Jr, JW Yunginger eds. Mosby, Washington, DC, p. 739-925.
23. Schleimer RP. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis 1990;141: 559-569.
24. Schleimer RP, Davidson DA, Peters SP, Lichtenstein LM. Inhibition of human basophil leukotriene release by antiinflammatory steroids. Int Arch Allergy Appl Immunol 1985;77: 241-243.
25. 4 in rats. Am J Resp Crit Care Med 1995;151:1143-1150.
26. Davidson FF, Lister MD, Dennis EA. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line. J Biol Chem 1990;265:5602-5609.
27. De Weck AL, Stadler BM, Urwyler A, et al. Cellular allergen stimulation test (CAST) - A new dimension in allergy diagnostics. Allergy Clin Immunol News 1993;5:9-14.
28. Crocker IC, Townley RG, Khan MM. Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology 1996;31:223-225.
29. Hong SL, Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of antiinflammatory corticosteroids. Proc Natl Acad Sci USA 1976;73:1730-1734.
30. 2 inhibitor which prevents prostaglandin generation. Nature 1979;278:456-459.
31. 2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 1980;77:2533-2536.
32. Schleimer RP, MacGlashan DW Jr, Gillespie E, Lichtenstein LM. Inhibition of basophil histamine release by antiinflammatory steroids. II. Studies on the mechanism of action. J Immunol 1982;129:1632-1636.
33. Schleimer RP, Lichtenstein LM, Gillespie E. Inhibition of basophil histamine release by anti-inflammatory steroids. Nature 1981;292:454-455.
34. Smith KA. T cell growth factor. Immunol Rev 1980;51:337-357.
35. Gillis S, Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T-cell Growth factor production II. The effect on the in vitro generation of cytolytic T-cells. J Immunol 1979;123: 1632-1638.
36. MacGlashan DW Jr, Hubbard WC. IL-3 alters free arachidonic acid generation in C5a-stimulated human basophils. J Immunol 1993;151: 6358-6369.
37. el Touny S, Khan W, Hannun Y. Regulation of platelet protein kinase C by oleic acid: kinetic analysis of allosteric regulation and effects on autophosphorylation, phorbol ester binding, and susceptibility to inhibition. J Biol Chem 1990;265:16437-16443.
38. Shinomura T, Asaoka Y, Oka M, et al. Synergistic action of diacylglycerol and unsaturated fatty acid from protein kinase C activation: its possible implications. Proc Natl Acad Sci USA 1991;88:5149-5153.
39. Warner JA, MacGlashan DW Jr. Protein kinase C (PKC) changes in human basophils: IgE-mediated activation is accompanied by an increase in total PKC activity. J Immunol 1989;142: 1669-1677.
40. Warner JA, MacGlashan DW Jr. Signal transduction events in human basophils: a comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine. J Immunol 1990;145:1897-1905.
41. Barton BE, Jakway JP, Smith SR, Siegel MI. Cytokine inhibition by a novel steroid, mometasone furoate. Immunolpharmacol-Immunotoxicol 1991; 13(3):251-261.